...
首页> 外文期刊>Applied Biological Chemistry >The potential of pharmacological activities of the multi-compound treatment for GERD: literature review and a network pharmacology-based analysis
【24h】

The potential of pharmacological activities of the multi-compound treatment for GERD: literature review and a network pharmacology-based analysis

机译:GERD多复方治疗药理活性的潜力:文献综述和基于网络药理学的分析

获取原文
           

摘要

The prevalence of gastroesophageal reflux disease (GERD) is rapidly increasing due to the adoption of a Westernized lifestyle; at the same time, safe and efficient treatment is required due to the side effects and refractoriness of proton pump inhibitors (PPIs). The frequently used multi-compound treatment for GERD in the current traditional Korean medicine (TKM) clinical field comprises Crassostrea gigas Thunberg shell (CGTS), Bambusae Caulis in Taeniam (BCT), Ponciri Fructus Immaturus (PFI), Scutellaria baicalensis Georgi (SBG), medicated leaven (ML) and Glycyrrhizae Radix et Rhizoma (GRR). The current review was based on “Kun-Shin-Choa-Sa” theory and network analysis was conducted to explore the potential pharmacological activities, including efficacy and mechanisms of action of multi-compound treatment against GERD. Hypergeometric test results showed that the targets of multi-compound treatment are significantly associated with GERD gene sets, consistent with the literature review findings. In particular, the enrichment analysis indicated that the SBG targets are related to the IL-17 signaling pathway, bile secretion, small-cell lung cancer, and non-small cell lung cancer, corroborating the literature review, particularly concerning anti-inflammatory effect. In the literature review, CGTS and BCT, classified as “Kun,” play a role in anti-acid, anti-inflammatory, and anti-oxidative effects. The complementary “Shin” herbs, PFI and SBG, showed functions related to improving the prolonged gastric emptying rate, peristalsis, and a gastric cytoprotective effect. With the role of “Choa,” ML was suggested to inhibit H. pylori growth and diminish gastric acid secretion, consistent with the gastric acid secretion pathway in the enrichment analysis. However, the enrichment analysis did not show any significantly related pathways for CGTS and PFI, which may reflect the lack of information in the KEGG database in terms of the link between GERD, its mechanisms, and the abundance of minerals in CGTS. Despite the pharmacological potential of multi-compound treatment, this study should be corroborated by well-designed future experimental studies.
机译:由于采用西化生活方式,胃食管反流疾病(GERD)的患病率迅速增加;同时,由于质子泵抑制剂(PPI)的副作用和耐火材料,需要安全和有效的处理。目前传统韩国药物(TKM)临床领域的常用多方复合处理包括鲫鱼(CGTS),Bambusae Caulis,在Taeniam(BCT),Ponciri Fructus Immaturus(PFI),Scutellaria Baicalensis Georgi(SBG) ,药物酵母酵素(ml)和甘草粒子radix等Rhizoma(GRR)。目前的审查是基于“昆新核心SA”理论和网络分析,探讨了潜在的药理学活动,包括对GERD的多重治疗的疗效和作用的作用机制。超高度测量测试结果表明,多复合处理的目标与GERD基因集明显相关,与文献综述结果一致。特别地,富集分析表明,SBG靶标与IL-17信号通路,胆汁分泌,小细胞肺癌和非小细胞肺癌有关,证实了文献综述,特别是关于抗炎作用。在文献综述,CGTS和BCT中,归类为“坤”在抗酸,抗炎和抗氧化作用中起作用。互补的“Shin”草药,PFI和SBG,显示出与改善延长的胃排空率,蠕动和胃细胞保护作用有关的功能。随着“CHOA”的作用,建议抑制H.幽门螺杆菌生长和减少胃酸分泌,与富集分析中的胃酸分泌途径一致。然而,浓缩分析没有显示CGT和PFI的任何显着相关的途径,这可能反映了GERD,其机制与CGT中矿物质的联系方面的KEGG数据库中缺乏信息。尽管有多种复合处理的药理潜力,但该研究应通过精心设计的未来实验研究来证实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号